Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis

Shock

Volumn 36, Issue 1, 2011, Pages 12-17

  Ware, Lorraine B ^a,c   Fessel, Joshua P ^a   May, Addison K ^a   Roberts, L Jackson ^b  

^a Department of Medicine ^*  (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lipid peroxidation; organ failure; oxidant stress; sepsis

Indexed keywords

FURAN DERIVATIVE; ISOFURAN; ISOPROSTANE; UNCLASSIFIED DRUG;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; KIDNEY FAILURE; LIPID PEROXIDATION; LIVER FAILURE; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MORTALITY; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; SEPSIS; THROMBOCYTOPENIA;

ACUTE KIDNEY INJURY; ACUTE LUNG INJURY; ADULT; AGED; BIOLOGICAL MARKERS; CRITICAL ILLNESS; F2-ISOPROSTANES; FEMALE; HUMANS; LIPID PEROXIDATION; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; SEPSIS;

EID: 79959743458     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318217025a     Document Type: Article

References (37)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003. (Pubitemid 36437931)
2. Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8:776-787, 2008.
3. Abraham E, Singer M: Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:2408-2416, 2007. (Pubitemid 47476242)
4. Montuschi P, Barnes P, Roberts LJ 2nd: Insights into oxidative stress: the isoprostanes. Curr Med Chem 14:703-717, 2007. (Pubitemid 46477722)
5. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ 2nd: A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387, 1990. (Pubitemid 120030630)
6. Montuschi P, Barnes PJ, Roberts LJ 2nd: Isoprostanes: markers and mediators of oxidative stress. FASEB J 18:1791-1800, 2004. (Pubitemid 39602265)
7. Roberts LJ, Morrow JD: Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505-513, 2000. (Pubitemid 30136031)
8. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, et al.: Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38:698-710, 2005. (Pubitemid 40249740)
9. Morrow JD, Roberts LJ: The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36:1-21, 1997. (Pubitemid 27387112)
10. Fessel JP, Porter NA, Moore KP, Sheller JR, Roberts LJ 2nd: Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci USA 99:16713-16718, 2002. (Pubitemid 36034038)
11. Fessel JP, Roberts LJ: Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension. Antioxid Redox Signal 7:202-209, 2005. (Pubitemid 40187937)
12. Siew E, Ware LB, Gebretsadik T, Shintani AK, Wickersham N, Bossert FR, Ikizler TA: Urine neutrophil gelatinase-asociated lipocalin (uNGAL) for the early detection of acute kidney injury in a prospective mixed adult ICU population. J Am Soc Nephrology 20:1823-1832, 2009.
13. Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, Schein R, Sibbald W: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
14. Il'yasova D, Morrow JD, Ivanova A, Wagenknecht LE: Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/ mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. Ann Epidemiol 14:793-797, 2004. (Pubitemid 39446401)
15. Morrow JD, Roberts LJI: Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymology 300:3-12, 1999. (Pubitemid 28500576)
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 13:818-829, 1985. (Pubitemid 15250137)
17. LeGall J, Lemshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963, 1993. (Pubitemid 24000804)
18. Bernard G: The Brussels Score. Sepsis 1:43-44, 1997.
19. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, the Consensus Committee: The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
20. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31, 2007.
21. Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB: Comparison of the SpO2/FiO2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or acute respiratory distress syndrome. Chest 132:410, 2007.
22. Powers JS, Roberts LJ 2nd, Tarvin E, Hongu N, Choi L, Buchowski M: Oxidative stress and multi-organ failure in hospitalized elderly people. J Am Geriatr Soc 56:1150-1152, 2008. (Pubitemid 351782719)
23. Mishra V, Baines M, Wenstone R, Shenkin A: Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 42:269-276, 2005. (Pubitemid 40961744)
24. Carpenter CT, Price PV, Christman BW: Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 114:1653-1659, 1998. (Pubitemid 128487489)
25. Ikizler TA, Morrow JD, Roberts LJ, Evanson JA, Becker B, Hakim RM, Shyr Y, Himmelfarb J: Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol 58:190-197, 2002. (Pubitemid 34994045)
26. Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E, Le P, Pupim LB, Ikizler TA, The PG: Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15:2449-2456, 2004. (Pubitemid 39159345)
27. Morrow JD, Moore KP, Awad JA, Ravenscraft MD, Marini G, Badr KF, Williams R, Roberts LJ 2nd: Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome. J Lipid Mediat 6:417-420, 1993. (Pubitemid 23152476)
28. Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ 2nd, Hoover RL, Badr KF: Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest 90:136-141, 1992.
29. Koyner JL, Sher Ali R, Murray PT: Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury? Nephron Exp Nephrol 109: e109Ye117, 2008.
30. Aleynik SI, Leo MA, Aleynik MK, Lieber CS: Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol Clin Exp Res 22:192-196, 1998. (Pubitemid 28139216)
31. Meagher EA, Barry OP, Burke A, Lucey MR, Lawson JA, Rokach J, FitzGerald GA: Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 104:805-813, 1999. (Pubitemid 29536366)
32. Salvemini D, Cuzzocrea S: Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 33:1173-1185, 2002. (Pubitemid 35246585)
33. Baldwin SR, Grum CM, Boxer LA, Simon RH, Ketai LH, Devall LJ: Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1(8471):11-14, 1986.
34. Chabot F, Mitchell JA, Gutteridge JMC, Evans TW: Reactive oxygen species in acute lung injury. Eur Respir J 11:745-757, 1998. (Pubitemid 28194873)
35. Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W: Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 25:180-185, 1999. (Pubitemid 29126844)
36. Bowler RW, Velsor LW, Duda B, Chan ED, Abraham E, Ware LB, Matthay MA, Day BJ: Pulmonary edema fluid antioxidants are depressed in acute lung injury. Crit Care Med 31:2309-2315, 2003. (Pubitemid 37100833)
37. Lykens MG, Davis WB, Pacht ER: Antioxidant activity of bronchoalveolar lavage fluid in the adult respiratory distress syndrome. Am J Physiol 262: L169YL175, 1992.